Cannabis, cannabinoids and psychosis: a balanced view
Author:
- 9 May 2023
- journal article
- editorial
- Published by Wiley in World Psychiatry
- Vol. 22 (2) , 231-232
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosisThe World Journal of Biological Psychiatry, 2022
- Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in DenmarkJAMA Psychiatry, 2021
- Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for SchizophreniaJAMA Psychiatry, 2021
- Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016Psychological Medicine, 2019
- The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control studyThe Lancet Psychiatry, 2019
- Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced PsychosisAmerican Journal of Psychiatry, 2018
- Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addictionBiological Psychiatry, 2005
- The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisNeuropsychopharmacology, 2004